Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-03-27
2007-03-27
Flood, Michele (Department: 1655)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S053000, C514S054000, C514S060000, C514S062000, C424S464000
Reexamination Certificate
active
10294121
ABSTRACT:
Compositions of plant carbohydrates for dietary supplements and nutritional support for promotion and maintenance of good health. Defined nutritionally effective amounts of one to eleven essential saccharides, glyconutrients, are used in various inventive compositions as dietary supplements. The dietary composition herein can include phytonutrients, vitamins, minerals, herbal extracts, and other non-toxic nutrients. The glyconutritional dietary supplement herein provides essential saccharides which are the building blocks of glycoproteins. These compositions, when administered orally or topically, have been found to improve the well being of mammals suffering from a variety of disorders.
REFERENCES:
patent: 3890438 (1975-06-01), Cayen et al.
patent: 3947601 (1976-03-01), Ortega
patent: 4260603 (1981-04-01), Pegel et al.
patent: 4466958 (1984-08-01), Morrison
patent: 4593046 (1986-06-01), Gruber
patent: 4665057 (1987-05-01), Nelson et al.
patent: 4735935 (1988-04-01), McAnalley
patent: 4777045 (1988-10-01), Vanderveer et al.
patent: 4837040 (1989-06-01), Yokoyama et al.
patent: 4851224 (1989-07-01), McAnalley
patent: 4855284 (1989-08-01), Emoedi
patent: 4859488 (1989-08-01), Kan et al.
patent: 4871557 (1989-10-01), Linscott
patent: 4917890 (1990-04-01), McAnalley
patent: 4957907 (1990-09-01), McAnalley
patent: 4959214 (1990-09-01), McAnalley
patent: 4966892 (1990-10-01), McAnalley
patent: 5021560 (1991-06-01), Montreuil et al.
patent: 5106616 (1992-04-01), McAnalley et al.
patent: 5106967 (1992-04-01), Mazur
patent: 5118673 (1992-06-01), Carpenter et al.
patent: 5202122 (1993-04-01), Graves et al.
patent: 5229118 (1993-07-01), Campbell
patent: 5284833 (1994-02-01), McAnalley et al.
patent: 5292729 (1994-03-01), Ashmead
patent: 5294434 (1994-03-01), King et al.
patent: 5296245 (1994-03-01), Clarke et al.
patent: 5308618 (1994-05-01), Konno et al.
patent: 5308838 (1994-05-01), McAnalley et al.
patent: 5378480 (1995-01-01), Carieri
patent: 5441943 (1995-08-01), McAnalley et al.
patent: 5443830 (1995-08-01), Moore et al.
patent: 5487894 (1996-01-01), Kovacs
patent: 5523087 (1996-06-01), Shlyankevich
patent: 5607693 (1997-03-01), Bonte et al.
patent: 5612039 (1997-03-01), Policappelli et al.
patent: 5710270 (1998-01-01), Maeda et al.
patent: 5827526 (1998-10-01), Dohnalek et al.
patent: 6258796 (2001-07-01), Richards
patent: 2004/0170706 (2004-09-01), McAnalley et al.
patent: 2004/0171583 (2004-09-01), McAnalley et al.
patent: 2005/0008713 (2005-01-01), McAnalley et al.
patent: 3935906 (1991-05-01), None
patent: 0052171 (1982-05-01), None
patent: 00561408 (1993-09-01), None
patent: 0562171 (1993-09-01), None
patent: 57/007420 (1982-01-01), None
patent: 58016065 (1983-05-01), None
patent: 59059624 (1984-04-01), None
patent: 59/112922 (1984-06-01), None
patent: 59112922 (1984-06-01), None
patent: 61106516 (1986-05-01), None
patent: 63-501221 (1988-05-01), None
patent: 63192722 (1988-08-01), None
patent: 63294766 (1988-12-01), None
patent: 02-503094 (1990-09-01), None
patent: 3052810 (1991-03-01), None
patent: 03-501624 (1991-04-01), None
patent: 03/255029 (1991-11-01), None
patent: 4235921 (1992-08-01), None
patent: 5262802 (1993-10-01), None
patent: 6007115 (1994-01-01), None
patent: 1995113001 (1995-05-01), None
patent: 07/242551 (1995-09-01), None
patent: 8081366 (1996-03-01), None
patent: 10279487 (1998-10-01), None
patent: 10279496 (1998-10-01), None
patent: 299607 (1997-03-01), None
patent: 2097041 (1997-11-01), None
patent: WO 90/01253 (1900-02-01), None
patent: WO 87/00052 (1987-01-01), None
patent: WO 89/06539 (1989-07-01), None
patent: WO/91/15214 (1991-10-01), None
patent: WO 9303727 (1993-04-01), None
patent: WO 9506068 (1995-03-01), None
patent: WO/98/06418 (1998-02-01), None
patent: WO 98/20900 (1998-05-01), None
Agarwal, O. P. et al. Angiology (1985), 36(8): 485-492. Prevention of atheromatous heart disease.
Jenkins, D. A. et al. British Medical Journal (1978), 1: 1392-4. Dietary fibers, fiber analogs, and glucose tolerance: importance of viscosity.
Robert K. Murray et al., Harper's Biochemistry, Appleton & Lange, 1996, pp. 648-649.
Singhal et al. (V, Singhal. P.C. et al. Current Science (1984), 53(2): 91. Role of Gum Arabica and Gum Catechu in glycemia and cholesterolemia.
Mathuram, L. N. et al. Cheiron (1981), 10(1): 1-5. Studies on the hypoglycemic effects of Strychonos potatorum and Acacia arabica on alloxan diabetes in rabbits.
Padron, J. L. et al. Nature (1967), 213: 1254-1255. Glucosamine acetoacetate condensate: a new anti-alloxan-diabetes factor.
U1, Agarwal, O. P. et al. Angiology (1985), 36(8): 485-492. Prevention of atheromatous heart disease.
V1, Jenkins, D. A. et al. British Medical Journal (1978), 1: 1392-4. Dietary fibers, fiber analogs, and glucose tolerance: importance of viscosity.
Balch, J F et al., Prescription for Nutritional Healing, 2ndEdition (1997), Avery Publishing Group (USA), pp. 7, 8, 12 and 43-46.
Murray R K et al., Harper's Biochemistry, Appleton & Lange, 1996, pp. 648-666.
Aloe Vera Research—Author unknown, Date of publication, if any, unknown.
Alton, G et al., Direct utilization of mannose for mammalian glycoprotein biosynthesis, Glycobiology, vol. 8, No. 3, 1998, pp. 285-295.
Bond, A et al., Distinct Oligosaccharide Content of Rheumatoid Arthritis-Derived Immune Complexes, Arthritis & Rheumatism, vol. 38, No. 6, 1995, pp. 744-749.
Bond, A et al., The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis (RA), juvenile chronic arthritis (JCA) and Sjögren's syndrome (SS) Clin exp Immunol (1996); vol. 105, pp. 99-103.
Bouic, P et al., Plant Sterols and Sterolins: A Review of Their Immune-Modulating Properties, Alternative Medicine Review, vol. 4, No. 3, 1999, pp. 170-177.
Chinnah, A et al., Antigen dependent adjuvant activity of a polydispersed β-(1,4)-linked acetylated mannan (acemannan), Vaccine, vol. 10, No. 8, 1992, pp. 551-557.
Clamp, J R et al., Study of the Carbohydrate Content of Mucus Glycoproteins from Normal and Diseased Colons, Clinical Science, vol. 61 (1981), pp. 229-234.
Cuddihy, J et al., The Presence of Total Polysaccharides in Sugar Production and Methods for Reducing Their Negative Effects, Midland Research Laboratories, Inc.; date of publication, if any, unknown.
Davis, R, Polysaccharide: The Magic Bullet, Inside Aloe.
Djeraba, A et al., In vivo macrophage activation in chickens with Acemannan, a complex carbohydrate extracted from Aloe vera, International Journal of Immunopharmacology, vol. 22 (2000), pp. 365-372.
Dwek, R A, Glycobiology: The function of sugar in the IgG molecule, Anat., vol. 187 (1995), pp. 279-292.
Edwards, C A et al., Viscosity of food gums determined in vitro related to their hypoglycemic actions, Am J Clin Nutr vol. 46 (1987), pp. 72-77.
Ercan, N, Effects of Glucose, Galactose, and Lactose Ingestion on the Plasma Glucose and Insulin Response in Persons With Non-Insulin-Dependent Diabetes Mellitus, Metabolism, vol. 42, No. 12 (1993), pp. 1560-1567.
Feizi, T, Significance of carbohydrate components of cell surfaces, Autoimmunity and autoimmune disease, Wiley, Chichester (Ciba Foundation Symposium 129): (1987), pp. 43-58.
Fukuda, M et al., Molecular Glycobiology, Oxford University Press, pp. 1-52.
Ghoneum, M, Anti-HIV Activity in Vitro of MGN-3, an Activated Arabinoxylane from Rice Bran, Biochemical and Biophysical Research Communications, vol. 243 (1998), pp. 25-29.
Hakomori, S, Aberrant Glycosylation in Cancer Cell Membranes as Focused on Glycolipids: Overview and Perspectives, Cancer Research, vol. 45 (1985), pp. 2405-2414.
Hara, H et al., Ingestion of Guar Gum Hydrolysate, a Soluble Fiber, Increase Calcium Absorption in Totally Gastrectomized Rats, J. Nutr., vol. 129 (1999), pp. 39-45.
Haydu, C et al., Medical Attributes of Aloe vera—The Aloe Plant, Wilkes University (1997), pp. 1-8.
Ikegami, S et al., Viscous Indigestible Polysaccharides Reduce Accumulation of Pentachlorobenzene in Rats, J. Nutr., vol. 124 (1994), pp. 754-760.
Kahlon, J et al., Inhibiton of AIDS virus replication by Acemannan in vitro, Mol
Fioretti William C.
McAnalley Bill H.
McDaniel H. Reginald
Moore D. Eric
Vennum Eileen P.
Flood Michele
Haynes and Boone LLP
Mannatech, Inc.
LandOfFree
Compositions of plant carbohydrates as dietary supplements does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions of plant carbohydrates as dietary supplements, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions of plant carbohydrates as dietary supplements will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3740257